1[1]Neal B,MacMahon S,Chapman N.Effects of ACE inhibitors,calcium antagonists,and other blood -pressure -lowering drugs:results of prospectively designed overviews of randomized trials.Lancet,2000,356:1955-1964
2[2]Mancia G,De Backer G,Dominiczak A,et al.2007 Guidelines for the management of arterial hypertension:The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).J Hypertens,2007,25:1105-1187
3[3]Satish S,Freeman DH jr,Ray L,et al.The relationship between blood pressure and mortality in the oldest old.J Am Geriatr Soc,2001,49:367-374
4[4]Amery A,birkenhgger W,Brixko P,et al.Mortality and morbidity results from the European Working Patty on High Blood Pressure in the Elderly trial.Lancet,1985,1:1349 -1354
5[5]Dahl of B,Liudhalm LH,Hansson L,et al.Morbidity and mortality in the Swedish Trial in Old Ptients with Hypertension (STOP Hypertension).Lancet,1991,338:1281-1285
6[6]Prevention of stroke by antihypertensive grug treatment in older persons with isolated systolic hypertension:final results of the Systolic Hypertension in the Elderly Program (SHEP).JAMA,1991,265:3255 -3264
7[7]Staessen JA,Fagard R,Thijs L,et al.Randomised doubleblind comparison of placebo and active treatment for older patients with isolated systolic hypertension:the Systolic Hypertension in Europe (syst-Eur) Trial Investigators.Lancet,1997,350:757 -764
8[8]Gueyflier F,Bulpitt C,Boissel JP,ey al.Antihypertensive drugs in very old people:a subgroup meta -analysis of randomized controlled trials.Lancet,1999,353:793 -796
9[9]Beckett NS,Peters R,Fletcher AE,et aL for the HYVET Study Group.Treatment of Hypertenson in Pticnts 80 Years of Age or Older.N Engl J Med,2008,358:1887-1898
10[10]Bnlpitt CJ,Bcckett NS,Cooke J,et al.Results of the pilot study for the Hypertension in the Very Elderly trial.J Hypertens,2003,21:2409 -2417
5Gueyffier F, Bulpitt C, Boissel JP, et al. Antihypertensive drugsin very old people : a subgroup meta - analysis of randomized con-trolled trials[ J]. Lancet, 1999, 353: 793 - 796.
9UKPDS, Group. Tight blood pressure control and risk of macro-vascular and microvascular complications in type 2 diabetes ( UK-PDS 38)[J]. BMJ, 1998,317:703 -713.
